Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cara Therapeutics, Inc. - Common Stock (NQ:CARA)

4.865 -0.035 (-0.71%)
Streaming Delayed Price Updated: 3:45 PM EDT, Apr 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cara Therapeutics, Inc. - Common Stock

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Cannabis Stock Movers For December 27, 2022
Via Benzinga
Marijuana Stock Movers For December 26, 2022
Via Benzinga
Cannabis Stock Movers For December 23, 2022
Via Benzinga
Marijuana Stock Movers For December 15, 2022
Via Benzinga
Cara Therapeutics Presents Results of Oral Difelikefalin In Painful Itching Disorder
Via Benzinga
Marijuana Stock Movers For December 9, 2022
Via Benzinga
Planned Government Move To Expand Access To Drugs For End-Stage Renal Disease Patients Could Shine The Spotlight On Unicycive
In the U.S., reimbursement of dialysis expenses by the Centers for Medicare & Medicaid Services (CMS) is done using a prospective payment system (PPS) which enables the payout of a predetermined amount... 
Via Benzinga
Cannabis Stock Movers For December 2, 2022
Via Benzinga
Cannabis Stock Movers For November 30, 2022
Via Benzinga
Bullish Thursday For Marijuana Stocks - Canopy Gwth, ReneSola Among Top Gainers
GAINERS: Canopy Gwth (NASDAQ:CGC) shares closed up 18.69% at $3.81 
Via Benzinga
Cara Therapeutics Reports Third Quarter 2022 Financial Results
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cara Therapeutics Announces Appointment of Lisa von Moltke, M.D., to its Board of Directors
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Gainers And Losers From November 2, 2022
GAINERS: LOSERS: RIV Capital (OTC:CNPOF) shares closed down 12.25% at $0.30 
Via Benzinga
Cara Therapeutics to Present at Upcoming Investor Conferences
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Gainers And Losers From October 27, 2022
GAINERS: LOSERS: Urban-gro (NASDAQ:UGRO) shares closed down 7.57% at $4.03 
Via Benzinga
Cara Therapeutics to Announce Third Quarter 2022 Financial Results on November 7, 2022
From Cara Therapeutics, Inc.
Via GlobeNewswire
Marijuana Stock Movers For October 17, 2022
GAINERS: Charlottes Web Holdings (OTC:CWBHF) shares closed up 17.06% at $0.80 
Via Benzinga
Bullish Sentiment Across The Cannabis Space - Check Full Movers For October 4, 2022
GAINERS: Charlottes Web Holdings (OTC:CWBHF) shares closed up 24.09% at $0.50 
Via Benzinga
Cannabis Stock Movers For October 3, 2022
GAINERS: Green Thumb Industries (OTC:GTBIF) shares closed up 10.99% at $10.40 
Via Benzinga
Bullish Wednesday For Marijuana Stocks - Cresco Labs, TerrAscend Among Top Gainers
GAINERS: Cresco Labs (OTC:CRLBF) shares closed up 7.83% at $2.63 
Via Benzinga
Cara Therapeutics Announces Difelikefalin (KORSUVA®) Injection New Drug Application Has Been Submitted in Japan
From Cara Therapeutics, Inc.
Via GlobeNewswire
Cannabis Stock Gainers And Losers From September 21, 2022
GAINERS: Icanic Brands (OTC:ICNAF) shares closed up 18.62% at $0.07 
Via Benzinga
Marijuana Stock Movers For September 19, 2022
GAINERS: Icanic Brands (OTC:ICNAF) shares closed up 16.92% at $0.08 
Via Benzinga
Marijuana Stock Movers For September 1, 2022
GAINERS: iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 17.65% at $0.06 
Via Benzinga
Marijuana Stock Movers For August 30, 2022
GAINERS: iAnthus Capital Hldgs (OTC:ITHUF) shares closed up 8.91% at $0.06 LOSERS: 
Via Benzinga
Marijuana Stock Movers For August 26, 2022
GAINERS: Charlottes Web Holdings (OTC:CWBHF) shares closed up 10.34% at $0.64 
Via Benzinga
Bullish Sentiment Across The Cannabis Space - Check Full Movers For August 24, 2022
GAINERS: Canopy Gwth (NASDAQ:CGC) shares closed up 13.08% at $3.89 
Via Benzinga
Bearish Monday For Marijuana Stocks
GAINERS: LOSERS: Canopy Gwth (NASDAQ:CGC) shares closed down 13.61% at $3.30 
Via Benzinga
Recap Of Friday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Cara Therapeutics Secures Swiss Regulatory Approval For Chronic Kidney Disease Candidate
The Swiss Agency for Therapeutic Products (Swissmedic) has approved Cara Therapeutics’ (NASDAQ: CARA) lead candidate KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS